Emergency icon Important Updates
Department Hematology and Medical Oncology
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English, Spanish
Surgeon No
Locations
Cleveland Clinic Main Campus
Primary Location

Cleveland Clinic Main Campus

Appointment:
216.444.5085
Desk:
216.445.3318
Fax:
216.444.9464
Specialties & Treatments

Treatment & Services

  • Cancer Center
  • CAR T-Cell Therapy
  • Cellular Therapy
  • Chemotherapy
  • Immunotherapy
View all 5 Treatment & Services +

Specialty in Diseases & Conditions

  • Acute Leukemia
  • Acute Lymphocytic Leukemia (ALL)
  • Acute Myeloid Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Chronic Myelomonocytic Leukemia (CMML)
  • Hematologic Malignancies
  • Leukemia
  • Lymphoma
  • Myelodysplastic Syndrome (MDS)
  • Myeloma
  • Myeloproliferative Neoplasms
View all 11 Specialties +
Insurance

Insurance

Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans
Biography

About John Molina, MD, MEd

Dr. John Molina completed his undergraduate degree (B.A in Latin American Studies) and obtained his M.D. at Brown University in Providence, RI as part of the eight-year Program in Liberal Medical Education (PLME). During medical school, he also received his Masters in Education from the Harvard Graduate School of Education in Cambridge, MA. Dr. Molina remained in Providence, RI for residency and completed combined Internal Medicine and Pediatrics training at Rhode Island Hospital and Hasbro Children's Hospital. Following residency, he pursued dual fellowship training in Adult Hematology at the National Institutes of Health (NIH) and Pediatric Hematology/Oncology through the Johns Hopkins/NIH joint training program. During fellowship, Dr. Molina worked as an Associate Investigator in the Hematologic Malignancies Section of the National Cancer Institute's Pediatric Oncology Branch under the mentorship of Dr. Nirali Shah. He was involved Phase I/II chimeric antigen receptor (CAR) T-cell trials for acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).

Dr. Molina's research focuses on optimizing outcomes for adolescent and young adult (AYA) patients with high-risk acute leukemias using immunotherapy and cellular therapy approaches. He is also committed to medical education as part of the American Society of Hematology's Medical Educator Institute and serves as an Associate Program Director for the Hematology/Oncology Fellowship Program. 

Education & Professional Highlights

Education & Professional Highlights

Appointed
2022

Education & Fellowships

Fellowship - Johns Hopkins/National Institutes of Health
Hematology/Oncology
Baltimore, MD United States
2022

Residency - Brown University - Rhode Island Hospital
Internal Medicine/Pediatrics
Providence, RI
2018

Medical Education - Alpert Medical School of Brown University
Providence, RI United States
2014

Graduate School - Harvard Graduate School of Education
Masters in Education
Cambridge, MA United States
2013

Undergraduate - Brown University
Latin American Studies
Providence, RI United States
2008

Certifications

  • Pediatrics
  • Internal Medicine - Hematology
  • Internal Medicine

Specialty Interests

Adolescent and Young Adult (AYA) Leukemia, Immunotherapy, Medical Education

Research & Publications

Research & Publications

See publications for John Molina, MD, MEd.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/17/2024, Dr. Molina has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Molina receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

  • American Society of Hematology

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Patient Satisfaction Reviews

52 Patient Satisfaction Reviews

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.

Overall Star Ratings
5 out of 5
Explains 5
Listens 5
Courtesy, Respect & Concern 5
Patient Rating of Doctor 5

5 Patient Comments

Reviewed on Apr 16, 2024

One of the best doctors I have ever been to.

Reviewed on Apr 9, 2024

John Molina, MD is simply top drawer in every possible way. L love that he listens, he pays close attention to my lab work and l think that he genuinely caresl l feel very fortunate to have him as my hematologist!!

Reviewed on Feb 20, 2024

Many of these questions are n/a, but there are no other options

Reviewed on Nov 14, 2023

I was amazed that I was able to make a new patient appointment so quickly. Dr. Molina was recommended by the members of a myelofibrosis support group that I belong to online.

Reviewed on Nov 14, 2023

Dr Molina is an amazing physician! I am newly diagnosed with myelofibrosis and he took time to explain everything to me. He listened to me and was very supportive. I am so thankful I found him.

Back to Top